Latest Insider Transactions at Propanc Biopharma, Inc. (PPCB)
This section provides a real-time view of insider transactions for Propanc Biopharma, Inc. (PPCB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Propanc Biopharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Propanc Biopharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 17
2021
|
James Andrew Nathanielsz CEO/CFO |
BUY
Grant, award, or other acquisition
|
Indirect |
8,728,000
+50.0%
|
-
|
|
Aug 17
2021
|
Julian Norman Kenyon Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,420,000
+50.0%
|
-
|